Exclusive: TPG's Par Pharmaceutical taps banks for IPO - sources

NEW YORK (Reuters) - Drugmaker Par Pharmaceutical Companies is preparing for an initial public offering later this year that could value the company at $3 billion to $4 billion, according to people...

from Reuters: Deals http://ift.tt/1BIDZL6